Malaysian Genomics Resource Centre Berhad (KLSE:MGRC)

Malaysia · Delayed Price · Currency is MYR

0.3050

-0.0100 (-3.17%)

At close: Aug 11, 2026

56.41% (1Y)

Market Cap	46.03M +72.1%
Revenue (ttm)	9.33M +83.0%
Net Income	-493.17K
EPS	-0.00
Shares Out	150.93M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	111,300
Open	0.3100
Previous Close	0.3150
Day's Range	0.3050 - 0.3100
52-Week Range	0.1550 - 0.3200
Beta	0.11
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About KLSE:MGRC

Malaysian Genomics Resource Centre Berhad, together with its subsidiaries, provides genetics, genomics, immunotherapy, and biopharmaceutical services in Malaysia. The company offers genetic screening services that includes Dtect and Origene genetic testing solutions which provides individuals with insights into genetic predispositions related to health risks, wellness, and lifestyle traits. It also provides immunotherapy and cell therapy which offers mesenchymal stem cells derived from ethically sourced human umbilical cords, as well as natural... [Read more]

Industry Commercial Physical and Biological Research

Founded 2004

Employees 33

Stock Exchange Bursa Malaysia

Ticker Symbol MGRC

Full Company Profile

Financial Performance

In 2025, KLSE:MGRC's revenue was 8.02 million, an increase of 45.29% compared to the previous year's 5.52 million. Losses were -2.38 million, -43.19% less than in 2024.

Financial Statements